ZIM Laboratories Limited develops, manufactures, and supplies generic pharmaceutical and nutraceutical products in India and internationally. The company provides its products in pre- formulation intermediates and finished formulations using modified release patterns in the oral solid dosage forms, such as granules, pellets, taste-masked powders, suspensions, tablets, capsules, dry syrup, and oral thin films. It offers therapeutics in the areas of urology, gastroenterology, CNS, antibiotics, anti-infectives, NSAIDs/pain analgesics, and vitamins and supplements. ZIM Laboratories Limited was incorporated in 1984 and is based in Nagpur, India.
Stock data | 2023 | Change |
---|---|---|
Price | $1.35 | N/A |
Market Cap | $65.58M | N/A |
Shares Outstanding | 48.73M | 0.00% |
Employees | 525.00 | N/A |
Shareholder Equity | 2.00B | 14.02% |
Valuation | 2023 | Change |
---|---|---|
P/E Ratio | 0.27 | N/A |
P/S Ratio | 1.39 | N/A |
P/B Ratio | 0.03 | N/A |
Growth | 2023 | Change |
---|---|---|
Return on Equity | 0.0015 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $47.11M | N/A |
Earnings | $2.92M | N/A |
EPS | 5.01 | N/A |
Earnings Yield | 3.72 | N/A |
Gross Margin | 0.4929 | N/A |
Operating Margin | 0.0894 | N/A |
Net income margin | 0.062 | N/A |
Financial Strength | 2023 | Change |
---|---|---|
Total Assets | $40.81M | N/A |
Total Debt | $7.41M | N/A |
Cash on Hand | $909.96K | N/A |
Debt to Equity | 0.0084 | -25.35% |
Cash to Debt | 0.1228 | 91.46% |
Current Ratio | $1.72 | 18.55% |